Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 2/20 | 0.58 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | MMP12 | P39900 | 2/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL6346718 | 0.83 | TSHR (0.50) | AGXTCA1CA2CA9NPC1 | |
| SCHEMBL11786079 | 0.79 | LPL (0.46) | CA2IDO1SMN1; SMN2CYP2A6TAAR1 | |
| SCHEMBL14201539 | 0.78 | CYP2A6 (0.52) | AGXTPARP10IDO1MAOBCYP1A2 | |
| SCHEMBL9617939 | 0.78 | AGXT (0.64) | AGXTPARP10CA1CA2CA9 | |
| SCHEMBL3161372 | 0.78 | AGXT (0.64) | AGXTPARP10CA1CA2CA9 | |
| SCHEMBL958300 | 0.78 | AGXT (0.64) | AGXTPARP10CA1CA2CA9 | |
| SCHEMBL13021169 | 0.78 | IDO1 (0.59) | CA1CA2CA9NPC1RAB9A | |
| Potassium SCHEMBL586332 | 0.76 | AGXT (0.61) | AGXTPARP10CA1CA2CA9 | |
| SCHEMBL12378 | 0.76 | AGXT (0.61) | AGXTPARP10CA1CA2CA9 | |
| Lithium SCHEMBL585057 | 0.76 | AGXT (0.61) | AGXTPARP10CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0355997-B1 | POLYMERISATION PROCESS AND CATALYST SYSTEM THEREFOR | POLYSAR LIMITED (CA) | 1993-09-15 | — | — | EP | claimed |
| US-4943616-A | LEWIS ACID AND PEROXIDE, ISOBUTYLENE | POLYSAR LIMITED (CA) | 1990-07-24 | — | — | US | claimed |
| US-4908421-A | Charging isobutylene, organic peroxy compound, Lewis acid to reaction vessel, polymerizing | POLYSAR LIMITED (CA) | 1990-03-13 | — | — | US | claimed |
| EP-0355997-A2 | Polymerisation process and catalyst system therefor | POLYSAR LIMITED (CA) | 1990-02-28 | — | — | EP | claimed |
| US-4255592-A | PEROXIDATION OF METHYL SUBSTITUTED BENZENE IN LIQUID PHASE, ALIPHATIC TERT-HYDROPEROXIDE PROMOTER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1981-03-10 | — | — | US | claimed |
| JP-55051031-A | — | — | None | — | — | JP | disclosed |
| JP-54157531-A | — | — | None | — | — | JP | disclosed |
| US-12551467-B2 | Compositions and methods of modulating S-nitrosylation | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-02-17 | — | — | US | disclosed |
| US-20240366568-A1 | COMPOSITIONS AND METHODS FOR TREATING TISSUE INJURY | UNIV CASE WESTERN RESERVE (US) | 2024-11-07 | — | — | US | disclosed |
| CN-118512442-A | Compositions and methods for reducing serum cholesterol and PCSK9 | 卡斯西部储备大学 | 2024-08-20 | — | — | CN | disclosed |
| WO-2024155618-A1 | COMPOSITIONS AND METHODS FOR TREATING WEIGHT GAIN AND/OR DISORDERS ASSOCIATED WITH ABNORMAL DE NOVO LIPOGENESIS, AND FAT ACCUMULATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2024-07-25 | — | — | WO | disclosed |
| CN-111356764-B | Compositions and methods for reducing serum cholesterol and PCSK9 | 卡斯西部储备大学 | 2024-05-24 | — | — | CN | disclosed |
| US-5616698-A | Polymer-supported solution synthesis of oligosaccharides | UNIVERSITY OF TORONTO INNOVATIONS FOUNDATION (CA) | 1997-04-01 | — | — | US | disclosed |
| EP-0355997-B1 | POLYMERISATION PROCESS AND CATALYST SYSTEM THEREFOR | POLYSAR LIMITED (CA) | 1993-09-15 | — | — | EP | disclosed |
| US-4943616-A | LEWIS ACID AND PEROXIDE, ISOBUTYLENE | POLYSAR LIMITED (CA) | 1990-07-24 | — | — | US | disclosed |
| US-4908421-A | Charging isobutylene, organic peroxy compound, Lewis acid to reaction vessel, polymerizing | POLYSAR LIMITED (CA) | 1990-03-13 | — | — | US | disclosed |
| EP-0355997-A2 | Polymerisation process and catalyst system therefor | POLYSAR LIMITED (CA) | 1990-02-28 | — | — | EP | disclosed |
| US-4255592-A | PEROXIDATION OF METHYL SUBSTITUTED BENZENE IN LIQUID PHASE, ALIPHATIC TERT-HYDROPEROXIDE PROMOTER | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1981-03-10 | — | — | US | disclosed |
| JP-S5551031-A | PREPARATION OF PHENOLS | MITSUBISHI GAS CHEM CO INC | 1980-04-14 | — | — | JP | disclosed |
| JP-S54157531-A | PREPARATION OF PHENOLS | MITSUBISHI GAS CHEM CO INC | 1979-12-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551467-B2 | Compositions and methods of modulating S-nitrosylation | AKR1A1, AKR1B1, AKR1D1 | AGXT 440/4885PARP10 1884/4885CA1 3586/4885 |
| US-20240366568-A1 | COMPOSITIONS AND METHODS FOR TREATING TISSUE INJURY | PDK4, AK1, PDK1 | AGXT 516/4885PARP10 2529/4885CA1 3036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.